Galenic formulations of organic compounds

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/165 (2006.01)

Patent

CA 2660138

The present invention relates to a dosage form for transmucosal administration comprising a therapeutically effective amount of aliskiren or a pharmaceutically acceptable salt thereof, and an excipient for transmucosal delivery, wherein the active ingredient is present in an amount of 0.001 to 80% by weight based on the total weight of the dosage form.

L'invention concerne une forme galénique pouvant être administrée par voie transmuqueuse, comprenant une quantité thérapeutiquement efficace d'aliskirène ou d'un de ses sels pharmaceutiquement acceptable, et un excipient permettant l'administration par voie transmuqueuse. La teneur en principe actif est comprise entre 0,001 et 80% en poids sur la base du poids totale de la forme galénique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Galenic formulations of organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenic formulations of organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic formulations of organic compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1648835

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.